Duchenne News Tags: Astellas Pharma

November 16, 2023
Astellas shares a Community Letter with information on results for ASP0367 for treatment of Duchenne.
September 1, 2022
On Sept. 1, 2022, Astellas announced that their Phase 1b study is now open at sites across the United States. They will be adding more sites as they become ready...